PL414906A1 - Pharmaceutical composition containing combination of vitamin K1 and D3 and its application - Google Patents

Pharmaceutical composition containing combination of vitamin K1 and D3 and its application

Info

Publication number
PL414906A1
PL414906A1 PL414906A PL41490615A PL414906A1 PL 414906 A1 PL414906 A1 PL 414906A1 PL 414906 A PL414906 A PL 414906A PL 41490615 A PL41490615 A PL 41490615A PL 414906 A1 PL414906 A1 PL 414906A1
Authority
PL
Poland
Prior art keywords
vitamin
application
pharmaceutical composition
composition containing
containing combination
Prior art date
Application number
PL414906A
Other languages
Polish (pl)
Inventor
Aneta Pakieła-Rajtkowska
Jarosław Wypych
Original Assignee
Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequoia Spółka Z Ograniczoną Odpowiedzialnością filed Critical Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL414906A priority Critical patent/PL414906A1/en
Publication of PL414906A1 publication Critical patent/PL414906A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja farmaceutyczna, zawierająca witaminę K1 i D3 oraz jej zastosowanie, w celu profilaktyki krwawień u niemowląt, karmionych piersią w pierwszych trzech miesiącach życia i w profilaktyce krzywicy. Kompozycja charakteryzuje się tym, że witamina K1 występuje w ilości 100 µg - 300 µg, a witamina D3 w ilości 400 IU (10 µg) - 1200 IU (30 µg).The subject of the application is a pharmaceutical composition containing vitamin K1 and D3 and its use for the prevention of bleeding in infants who are breastfed in the first three months of life and for the prevention of rickets. The composition is characterized in that vitamin K1 is present in the amount of 100 µg - 300 µg, and vitamin D3 in the amount of 400 IU (10 µg) - 1200 IU (30 µg).

PL414906A 2015-11-23 2015-11-23 Pharmaceutical composition containing combination of vitamin K1 and D3 and its application PL414906A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL414906A PL414906A1 (en) 2015-11-23 2015-11-23 Pharmaceutical composition containing combination of vitamin K1 and D3 and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL414906A PL414906A1 (en) 2015-11-23 2015-11-23 Pharmaceutical composition containing combination of vitamin K1 and D3 and its application

Publications (1)

Publication Number Publication Date
PL414906A1 true PL414906A1 (en) 2017-06-05

Family

ID=58793722

Family Applications (1)

Application Number Title Priority Date Filing Date
PL414906A PL414906A1 (en) 2015-11-23 2015-11-23 Pharmaceutical composition containing combination of vitamin K1 and D3 and its application

Country Status (1)

Country Link
PL (1) PL414906A1 (en)

Similar Documents

Publication Publication Date Title
JOP20230073A1 (en) 1,3-Thiazol-2-yl substituted benzamides
CL2020000632A1 (en) Composition and method for the treatment of autism.
BR112017017217A2 (en) A composition comprising ramnolipid and siloxane.
BR112017018276A2 (en) ? composition comprising peptidase and biotensive agent and their use?
DOP2018000297A (en) DERIVATIVE OF GLUCAGON, CONJUGATE OF THE SAME, COMPOSITION THAT INCLUDES THE SAME AND THERAPEUTIC USE OF THE SAME
CO2017005626A2 (en) A composition comprising bacteroides thetaiotaomicron
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
EA201991447A1 (en) VISCOSITY REDUCTION OF PHARMACEUTICAL COMPOSITIONS
CL2017000136A1 (en) Sugar compositions for direct compression tablet formation
MX381155B (en) AGE-ADAPTED NUTRITIONAL COMPOSITIONS WITH VARIABLE PROTEIN CONTENT.
BR112017023636A2 (en) dietary supplement
EA202090732A1 (en) TRANSDERMAL ADMINISTRATION FORMULATIONS
BR112017019309A2 (en) Method for preparing confectionery fillings
BR112018011476A2 (en) vitamin formulation
JOP20170127A1 (en) Combination formulation of three antiviral compounds
BR112018068173A2 (en) Child nutrition that provides metabolic benefits.
PL414906A1 (en) Pharmaceutical composition containing combination of vitamin K1 and D3 and its application
MX2017004909A (en) Tryptamide compositions and methods of use.
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations
PL414904A1 (en) Pharmaceutical composition containing vitamin K1 and its application
EA201891752A2 (en) PHARMACEUTICAL COMPOSITION TO IMPROVE CONDITION DURING CHRONIC RENAL INSUFFICIENCY OR TO PREVENT ITS PROGRESSION
PL414902A1 (en) Pharmaceutical composition containing combination of vitamin K1 and K2 and its application
AR108105A1 (en) NA₂-IMP ANTIAGLOMERANT SALES TOTAL OR PARTIALLY DEHYDRATED, AND COMPOSITIONS OF THE SAME AND METHODS TO REDUCE COMPOSITION AGLOMERATION
PL414903A1 (en) Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application
AR102546A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRINE AND METHOD FOR THE MODULATION OF EXPRESSION OF SEROTONERERGIC RECEIVER